Investors remain calm as war unfolds

Issue of the week: Europe’s capitulation Trump’s ...

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Investors have a lot to think about as the president’s policies gather momentum

Following a trip in May to a US investment conference to meet with company bosses, James Harries, the manager of STS Global Trust, reported that, “as ever one cannot fail to be impressed by the sheer

Investors should consider shifting their focus to ‘old economy’ stocks rather than technology

The EU’s trade deal with US president Donald Trump drew furious reactions in Paris and Berlin (see our politics page), but behind the theatrics the deal seems likely to be approved. The unequal accord